Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

TPEX/6493 stock hub

TPEX/6493 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/6493is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

940.6M

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/6493

In the news

Latest news · TPEX/6493

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/En/a

P25 14.4P50 18P75 31.9

ROE-6.5

P25 -16.2P50 0.3P75 9.8

ROIC-4.4

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/6493 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

201

Groups with data

Currency

TWD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	138
Employees Change	20%
Employees Change Percent	16.95
Enterprise value	TWD 1.1B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	TW0006493000
Last refreshed	2026-05-10
Market cap	TWD 940.6M
Price	TWD 31
Price currency	TWD
Rev Per Employee	2,890,434.78x
Sector	Healthcare
Sic	3843
Symbol	tpex/6493
Website	https://www.ttbio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.26%
EV Earnings	-49.86x
EV/EBITDA	84.58x
EV/FCF	-21.66x
EV/Sales	2.66x
FCF yield	-5.21%
P/B ratio	2.63x
P/S ratio	2.36x
PE Ratio10 Y	98.22x
PE Ratio5 Y	145.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-5.32%
EBITDA Margin	1.21%
Gross margin	17.63%
Gross Profit	TWD 70.3M
Gross Profit Growth	-13.87%
Gross Profit Growth Q	-29.7%
Gross Profit Growth3 Y	-2.13%
Gross Profit Growth5 Y	-7.77%
Net Income	TWD -21.3M
Net Income Growth Years	0%
Pretax Margin	-5.3%
Profit Margin	-5.34%
Profit Per Employee	TWD -154,348
ROA	-2.16
Roa5y	0.81
ROCE	-4.72
ROE	-6.53
Roe5y	2.67
ROIC	-4.44
Roic5y	1.59

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	5.23%
Cagr1y	91.27%
Cagr3y	6.43%
Cagr5y	8.01%
Div CAGR3	-45.7%
Div CAGR5	-16.74%
EPS Growth Years	0
Revenue Growth	27.8x
Revenue Growth Q	3.43x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	11.97x
Revenue Growth5 Y	0.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.65
Assets	TWD 622.4M
Cash	TWD 53.7M
Current Assets	TWD 410.9M
Current Liabilities	TWD 173.1M
Debt	TWD 175.1M
Debt EBITDA	TWD 13.95
Debt Equity	TWD 0.49
Debt FCF	TWD -3.57
Equity	TWD 357.4M
Interest Coverage	-3.89
Liabilities	TWD 265.1M
Long Term Assets	TWD 211.5M
Long Term Liabilities	TWD 92M
Net Cash	TWD -121.4M
Net Cash By Market Cap	TWD -12.9
Net Debt EBITDA	TWD 25.23
Net Debt Equity	TWD 0.34
Tangible Book Value	TWD 324.6M
Tangible Book Value Per Share	TWD 10.8
WACC	7.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.37
Inventory Turnover	1.35
Net Working Capital	TWD 276.7M
Quick ratio	0.69
Working Capital	TWD 237.8M
Working Capital Turnover	TWD 1.96

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-12.2%
Dividend Growth	-33.31%
Dividend Growth Years	0%
Dividend per share	TWD 0.25
Dividend Years	4
Dividend Yield	0.8%
Ex Div Date	2025-07-28
Last Dividend	TWD 0.2
Payout Frequency	Annual

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	66.49%
1Y total return	91.19%
200-day SMA	31.16
3Y total return	20.55%
50-day SMA	26.9
50-day SMA vs 200-day SMA	50under200
5Y total return	47.01%
All Time High	80
All Time High Change	-61.25%
All Time High Date	2015-01-08
All Time Low	16.45
All Time Low Change	88.45%
All Time Low Date	2025-04-30
ATR	2.55
Beta	0.73
Beta1y	0.29
Beta2y	0.36
Ch YTD	14.39
High	31.5
High52	80
High52 Date	2025-09-12
High52ch	-61.25%
Low	30.5
Low52	16.8
Low52 Date	2025-05-08
Low52ch	84.52%
Ma50ch	15.22%
Price vs 200-day SMA	-0.51%
RSI	58.51
RSI Monthly	54.55
RSI Weekly	53.15
Sharpe ratio	1.02x
Sortino ratio	2.52
Total Return	-11.4%
Tr YTD	14.39
Tr1m	41.55%
Tr1w	-3.73%
Tr3m	14.82%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD -21.2M
Operating margin	-5.32

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,232,130%
Net Borrowing	-62,973,000
Shares Insiders	2.13%
Shares Institutions	5.78%
Shares Out	30,050,000
Shares Qo Q	24.46%
Shares Yo Y	12.2%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -49.1M
Average Volume	286,824.05x
Bv Per Share	11.89
CAPEX	TWD -8M
Ch10y	19.32
Ch1m	41.55
Ch1w	-3.73
Ch1y	82.35
Ch3m	14.82
Ch3y	8.39
Ch5y	29.17
Ch6m	2.31
Change	3.33%
Change From Open	0.81
Close	30
Days Gap	2.5
Depreciation Amortization	26,041,000
Dollar Volume	4,470,510
Earnings Date	2026-05-14
EBIT	TWD -21.2M
EBITDA	TWD 4.8M
EPS	TWD -0.79
F Score	2
FCF	TWD -49M
FCF EV Yield	-4.62x
FCF Per Share	TWD -1.63
Financing CF	21,132,000
Fiscal Year End	December
Founded	2,012
Income Tax	TWD 171,000
Investing CF	-8,971,000
Is Primary Listing	1
Last Earnings Date	2025-11-14
Last Report Date	2025-12-31
Ma150	31.74
Ma150ch	-2.33%
Ma20	28.27
Ma20ch	9.66%
Net CF	-28,849,000
Next Earnings Date	2026-05-14
Open	30.75
Payment Date	2025-08-15
Position In Range	50
Ppne	157,439,000
Price Date	2026-05-08
Price EBITDA	TWD 196
Ptbv Ratio	2.9
Relative Volume	0.51x
Revenue	398,880,000x
SBC By Revenue	0.02x
Share Based Comp	88,000
Tax By Revenue	0.04x
Tr6m	2.31%
Volume	144,210
Z Score	2.66

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/6493 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$0.25 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-16.7%

0 consecutive years of growth

Total shareholder yield

-11.4%

Next ex-dividend date: 2025-07-28

Performance

TPEX/6493 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/6493?

Insider, institutional, and short-interest positioning.

Institutional ownership

+5.8%

Share of float held by funds and institutions

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+12.2%

Negative means the company is buying back shares.

Technical

TPEX/6493 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.5

Neutral momentum band

Price vs 200-day MA

-0.5%

50/200-day relationship not available

Beta (5Y)

0.73

Less volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/6493

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/6493 stock rating?

tpex/6493 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/6493 analysis?

The full report lives at /stocks/tpex/6493/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/6493?

The latest report frames tpex/6493 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/6493 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.